Real-World Data Confirm Efficacy of Dupilumab in Severe EoE
Dupilumab demonstrated real-world efficacy in patients with severe, treatment-refractory fibrostenotic eosinophilic esophagitis, most of whom would not have qualified for prior clinical trials.
Medscape Medical News
source https://www.medscape.com/viewarticle/996536?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/996536?src=rss
Comments
Post a Comment